Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Dec;26(3):403-13.

Studies on the immune status of children with acute lymphocytic leukaemia. I. Early phase before and after first remission

Studies on the immune status of children with acute lymphocytic leukaemia. I. Early phase before and after first remission

W H Hitzig et al. Clin Exp Immunol. 1976 Dec.

Abstract

Seventeen children of 2-15 years of age with newly diagnosed untreated acute lymphatic leukaemia (ALL) were evaluated with a number of immunological tests: for humoral immunity serum immunoglobulins and reactive antibody formation against three antigens (diphtheria, tetanus, KLH); for cell-mediated immunity in vitro response of blood lymphocytes against PHA; membrane characteristics of blood lymphocytes and lymphoid blasts for both B and T cells. The tests were repeated in thirteen patients who attained full remission. In the majority (twelve cases) no surface markers were detected (null-cell leukaemia), one patient fulfilled the criteria for a T-cell leukaemia with thymoma. Four patients had rather high absolute B-cell counts, but did not fulfill all the criteria for B-cell leukaemia; three of them died before remission. Immune globulin concentrations were only slightly changed, antibody formation, both primary and anamnestic, was possible. PHA response was extremely low in the initial phase, but normal immediately after remission. During remission all patients were markedly depleted in both their B- and T-cell compartment.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1965 Aug 1;122:423-40 - PubMed
    1. Int Arch Allergy Appl Immunol. 1958;13(1-2):1-38 - PubMed
    1. Mayo Clin Proc. 1974 Aug;49(8):515-8 - PubMed
    1. Adv Immunol. 1974;19(0):67-216 - PubMed
    1. Clin Immunol Immunopathol. 1973 Jul;1(4):499-510 - PubMed

Substances

LinkOut - more resources